DJIA 16,614.81 215.14 1.31%
NASDAQ 4,419.48 103.40 2.40%
S&P 500 1,941.28 37.27 1.96%
market minute promo

Mylan Inc. (NASDAQ: MYL)



company name or ticker
Company Photos
(Click to zoom)

US Stock Futures Down Ahead Of Industrial Production Report

Mylan In Pact With Gilead To Accelerate Access To Hepatitis C

Mylan to Acquire U.S. Rights to Arixtra for up to $300M - Analyst Blog

Strong Portfolio Will Drive Growth For Mylan

Sector Update: Health-Care Shares Mixed Ahead of Opening Bell

Sector Update: Health Care

Mylan to Acquire U.S. Rights to Arixtra Injection From Aspen

Hospira Down on Legal Blow; Court Allows Generic Precedex - Analyst Blog

Gilead Down on Likely Sovaldi Generic Deal in Poor Nations - Analyst Blog

Is It Time to Buy Actavis plc Stock?

Shares of specialty drugmaker Actavis have been hitting all-time highs lately. With an acquisition-fueled revenue bonanza taking place, is it time to buy shares of this red-hot biopharma?
See More Articles...